About Epycure
Epycure is a Healthcare company based in Paris (France) founded in 2018 by Angelique d'Esclaibes and Paul Etienne Jacob. It operates as a manufacturer of vitamin supplements. Epycure has raised $2.96 million across 1 funding round from investors including Founders Future, Pierre Kosciusko Morizet and Joan Burkovic. Its website epycure.com draws about 93 thousand monthly visits. Epycure offers products and services including Boost métabolisme, Gummies solaires, Cure multivitamines+, Boost immunité, and Cure cheveux & ongles. Its focus areas include Traditional Nutraceuticals, Dietary Supplements and Gummies.
Company details
The company offers personalized supplements that they deliver to the homes of its customers. The company offers monthly subscriptions for its vitamins
- Headquarters Paris, France
- Founders Angelique d'Esclaibes, Paul Etienne Jacob
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website epycure.com
- Social LinkedIn Facebook Instagram
- Total Equity Funding$2.96M (USD)
in 1 rounds
- Latest Funding Round$2.96M (USD), Seed
Apr 2021
- InvestorsFounders Future
& 5 more
Products & Services of Epycure
Epycure offers a comprehensive portfolio of products and services, including Boost métabolisme, Gummies solaires, Cure multivitamines+, Boost immunité, and Cure cheveux & ongles.
Stimulates energy expenditure and fat burning.
Prepares skin for sun and enhances tanning.
Provides essential vitamins for overall health support.
Strengthens the immune system naturally.
Promotes hair growth and nail strength.
Funding Insights of Epycure
Epycure has successfully raised a total of $2.96M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.96 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.96M
- Total Rounds 1
- Last Round Seed — $2.96M
- First Round $2.96M
(Apr 2021)
- Investors Count 6
All 1 funding rounds of Epycure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $2.96M | Seed | – | Founders Future |
6 investors in total: 1 institutional and 5 angel.
Investors in Epycure
Epycure has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Founders Future, Pierre Kosciusko Morizet and Joan Burkovic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A venture capital firm focused on tech entrepreneurs is operated. | – | foundersfuture.com | Paris, France | |
PK Pierre Kosciusko Morizet | French entrepreneur, angel investor, co-founder of PriceMinister, active in Indian startups | – | unknown_3ac626158754456eb | - |
JB Joan Burkovic | Angel investor and fintech entrepreneur, co-founder of Bankin’ and Bridge. | – | unknown_590cbe1d117945e0a | - |
MO Martin Ohannessian | Angel investor and entrepreneur, founder of The Back Room, active in Indian startups | – | unknown_2824ba3919ff4794b | - |
PA Paul- Ambroise Archambeaud | - | – | unknown_7f0cb09f85964fc2a | - |
JF Jean- François Lahet | - | – | unknown_36e4582ae51f428f9 | - |
Investor details for Epycure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Epycure
4 people are tracked at Epycure (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Angelique d'Esclaibes | Co-Founder | Leadership |
Paul Etienne Jacob | Co-Founder | Leadership |
Mathilde Walker | Responsable Digital | Team |
Jérôme Joseph Marie | Responsable Administration Des Ventes Et Commercial | Team |
Complete people profiles for Epycure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Epycure
2 dated milestones of Epycure across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Epycure is founded.
- Funding First funding round of $3.0M.
Web traffic of Epycure
The website of Epycure (epycure.com) receives about 92.9K visits a month.
- Monthly visits92.9K
▲ 126% vs previous month
Websites whose visitors overlap most with Epycure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
myvitamins.fr | myvitamins.fr | 100% | – | #1,132,554 | – |
luxeol.com | luxeol.com | 100% | – | #183,874 | – |
nutrivie.com | nutrivie.com | 99% | – | #1,223,076 | – |
bears-with-benefits.fr | bears-with-benefits.fr | 94% | – | #1,724,453 | – |
| lashilebeauty.com | 94% | 78.3K | #473,691 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Epycure
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as Epycure (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epycure
Complete news archive for Epycure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epycure
Epycure was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Epycure is headquartered in Paris, France.
Epycure is a funded company, having raised a total of $2.96M across 1 funding round to date. The company's 1st funding round was a Seed of $2.96M, raised on Apr 2021.
The company offers personalized supplements that they deliver to the homes of its customers. The company offers monthly subscriptions for its vitamins.
Epycure offers Boost métabolisme, Gummies solaires, Cure multivitamines+, Boost immunité, and Cure cheveux & ongles.
Epycure has 6 investors. Key investors include Founders Future, Pierre Kosciusko Morizet, Joan Burkovic, Martin Ohannessian, and Paul- Ambroise Archambeaud.